Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Comparison of CT, PET, and PET/CT for staging of patients with indolent non-hodgkin's lymphoma: statistical errors in Fueger et al. (2009).

White LR.

Mol Imaging Biol. 2012 Aug;14(4):397-8; author reply 399-401. doi: 10.1007/s11307-011-0513-3. No abstract available.

PMID:
21814856
2.

Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma.

Fueger BJ, Yeom K, Czernin J, Sayre JW, Phelps ME, Allen-Auerbach MS.

Mol Imaging Biol. 2009 Jul-Aug;11(4):269-74. doi: 10.1007/s11307-009-0200-9. Epub 2009 Mar 27.

3.

A case of advanced non-Hodgkin's lymphoma involving the prostate: staging and treatment monitoring using F-18 FDG PET/CT imaging.

Cimarelli S, Lachenal F, Ricard F, Chassagne-Clément C, Heudel PE, Janody P, Sebban C.

Clin Nucl Med. 2010 Jun;35(6):425-7. doi: 10.1097/RLU.0b013e3181db4ca9. No abstract available.

PMID:
20479591
4.

[18F-FDG uptake of lymphoma lesions of various histological subtypes].

Ma LF, Fan W.

Ai Zheng. 2009 Apr;28(4):425-30. Chinese.

PMID:
19622306
5.

Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi YE, Larson SM, Yeung HW.

J Clin Oncol. 2005 Jul 20;23(21):4643-51. Epub 2005 Apr 18.

PMID:
15837966
6.

[Non-Hodgkin's lymphoma staging: a prospective study of the value of positron emission tomography/computed tomography (PET/CT) versus PET and CT].

Rodríguez-Vigil Junco B, Gómez León N, Pinilla Fernández I, del Campo L, Hernández Maraver D, Coya J.

Med Clin (Barc). 2011 Oct 8;137(9):383-9. doi: 10.1016/j.medcli.2010.10.031. Epub 2011 Jun 23. Spanish.

PMID:
21703647
7.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
8.

[Non-Hodgkin's lymphoma staging with PET-CT scan].

Setoain X, López-Guillermo A.

Med Clin (Barc). 2011 Oct 8;137(9):402-4. doi: 10.1016/j.medcli.2011.04.010. Epub 2011 Jun 22. Spanish. No abstract available.

PMID:
21696781
9.

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.

Bodet-Milin C, Kraeber-Bodéré F, Moreau P, Campion L, Dupas B, Le Gouill S.

Haematologica. 2008 Mar;93(3):471-2. doi: 10.3324/haematol.12013.

10.

The role of PET in lymphoma.

Jhanwar YS, Straus DJ.

J Nucl Med. 2006 Aug;47(8):1326-34. Review.

11.

[The value of integrated PET-CT images in 2 lymphoma patients with skeletal localisations].

Geerts MC, Quarles van Ufford HM, Kramer MH, van Waes PF, de Klerk JM.

Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):204-9. Dutch.

PMID:
16471237
12.

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.

PMID:
14644890
14.

Giant cardiac tumour thrombus on staging contrast enhanced ¹⁸F-FDG PET/CT in a case of non-Hodgkin's lymphoma.

Jeph S, Thakur K, Shamim SA, Verma K, Aggarwal B, Aggarwal A.

Rev Esp Med Nucl Imagen Mol. 2014 Sep-Oct;33(5):328-9. doi: 10.1016/j.remn.2013.10.015. Epub 2014 Mar 4. No abstract available.

15.

Stage IE non-Hodgkin's thyroid lymphoma on (18)F-FDG-PET/CT.

Mehta A, Muthukrishnan A.

Hell J Nucl Med. 2011 May-Aug;14(2):186-7. No abstract available.

PMID:
21761029
16.

The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.

Ustaalioglu BB, Seker M, Bilici A, Canpolat N, Yıldirim E, Kefeli U, Ustaalioglu R, Yilmaz BE, Salepci T, Ozdemir N, Gumus M.

Med Oncol. 2011 Mar;28(1):258-64. doi: 10.1007/s12032-010-9446-y. Epub 2010 Feb 13.

PMID:
20155405
17.

F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.

Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A.

Pediatr Radiol. 2006 Jun;36(6):524-31. Epub 2006 Apr 19.

PMID:
16622665
18.

Positron emission tomography in the management of patients with indolent non-Hodgkin's lymphoma.

Naumann R, Beuthien-Baumann B.

Clin Lymphoma. 2003 Jun;4(1):50-1. No abstract available.

PMID:
12837155
19.

Novel imaging techniques in NHL: clinical results with PET imaging.

Buchmann I, Reske SN.

Ann Hematol. 2001;80 Suppl 3:B54-7. Review. No abstract available.

PMID:
11757709
20.

Unusual discrepancy between CT and PET/CT in the initial staging of Hodgkin's lymphoma.

Michelis FV, Exarhos DN, Tzannou IA, Karmiris T, Nikiforakis E.

Acta Oncol. 2011 Apr;50(3):474-6. doi: 10.3109/0284186X.2010.509735. Epub 2010 Aug 17. No abstract available.

PMID:
20715895

Supplemental Content

Support Center